[go: up one dir, main page]

IT8619109A0 - THERAPEUTIC USE OF FRUCTOSE-1,6-DIPHOSPHATE FOR PROTECTION AGAINST TOXICITY INDUCED BY THE ADMINISTRATION OF ANTHRACYCLINICAL ANTI-CANCER DRUGS. - Google Patents

THERAPEUTIC USE OF FRUCTOSE-1,6-DIPHOSPHATE FOR PROTECTION AGAINST TOXICITY INDUCED BY THE ADMINISTRATION OF ANTHRACYCLINICAL ANTI-CANCER DRUGS.

Info

Publication number
IT8619109A0
IT8619109A0 IT8619109A IT1910986A IT8619109A0 IT 8619109 A0 IT8619109 A0 IT 8619109A0 IT 8619109 A IT8619109 A IT 8619109A IT 1910986 A IT1910986 A IT 1910986A IT 8619109 A0 IT8619109 A0 IT 8619109A0
Authority
IT
Italy
Prior art keywords
anthracyclinical
diphosphate
fructose
administration
protection against
Prior art date
Application number
IT8619109A
Other languages
Italian (it)
Other versions
IT1204764B (en
Inventor
Giuseppe Lazzarino
Annarita Viola
Luciano Mulieri
Original Assignee
Foscama Biomed Chim Farma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Foscama Biomed Chim Farma filed Critical Foscama Biomed Chim Farma
Priority to IT19109/86A priority Critical patent/IT1204764B/en
Publication of IT8619109A0 publication Critical patent/IT8619109A0/en
Priority to GB8701058A priority patent/GB2185398B/en
Priority to FR878700440A priority patent/FR2600892B1/en
Priority to JP62008863A priority patent/JPS62228020A/en
Priority to DE19873701162 priority patent/DE3701162A1/en
Application granted granted Critical
Publication of IT1204764B publication Critical patent/IT1204764B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • C07H11/04—Phosphates; Phosphites; Polyphosphates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
IT19109/86A 1986-01-17 1986-01-17 THERAPEUTIC USE OF FRUCTOSE-1,6-DIPHOSPHATE FOR THE PROTECTION AGAINST TOXICITY INDUCED BY THE ADMINISTRATION OF ANTHRACYCLINIC ANTI-TUMORAL AGENTS IT1204764B (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
IT19109/86A IT1204764B (en) 1986-01-17 1986-01-17 THERAPEUTIC USE OF FRUCTOSE-1,6-DIPHOSPHATE FOR THE PROTECTION AGAINST TOXICITY INDUCED BY THE ADMINISTRATION OF ANTHRACYCLINIC ANTI-TUMORAL AGENTS
GB8701058A GB2185398B (en) 1986-01-17 1987-01-16 Use of fructose-1,6-diphosphate to protect against the toxic effects of antitumour drugs
FR878700440A FR2600892B1 (en) 1986-01-17 1987-01-16 USE OF FRUCTOSE-1,6-DIPHOSPHATE FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION FOR PROTECTION AGAINST TOXICITY INDUCED BY THE ADMINISTRATION OF ANTHRACYCLINES AND COMPOSITIONS THEREOF
JP62008863A JPS62228020A (en) 1986-01-17 1987-01-16 Protector containing fructose 1,6 diphosphate as essential component from antitumoral toxicity
DE19873701162 DE3701162A1 (en) 1986-01-17 1987-01-16 NEW THERAPEUTIC USE OF FRUCTOSE-1,6-DIPHOSPHATE FOR PROTECTION AGAINST TOXICITY, CAUSED BY LONG-TERM ADMINISTRATION OF ANTITUMOR MEDICINES OF THE ANTHRACYCLIN SERIES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT19109/86A IT1204764B (en) 1986-01-17 1986-01-17 THERAPEUTIC USE OF FRUCTOSE-1,6-DIPHOSPHATE FOR THE PROTECTION AGAINST TOXICITY INDUCED BY THE ADMINISTRATION OF ANTHRACYCLINIC ANTI-TUMORAL AGENTS

Publications (2)

Publication Number Publication Date
IT8619109A0 true IT8619109A0 (en) 1986-01-17
IT1204764B IT1204764B (en) 1989-03-10

Family

ID=11154678

Family Applications (1)

Application Number Title Priority Date Filing Date
IT19109/86A IT1204764B (en) 1986-01-17 1986-01-17 THERAPEUTIC USE OF FRUCTOSE-1,6-DIPHOSPHATE FOR THE PROTECTION AGAINST TOXICITY INDUCED BY THE ADMINISTRATION OF ANTHRACYCLINIC ANTI-TUMORAL AGENTS

Country Status (5)

Country Link
JP (1) JPS62228020A (en)
DE (1) DE3701162A1 (en)
FR (1) FR2600892B1 (en)
GB (1) GB2185398B (en)
IT (1) IT1204764B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE139699T1 (en) * 1988-08-19 1996-07-15 Univ Australian PHOSPHOSUGAR BASED ANTI-INFLAMMATORY AND/OR IMMUNITY SUPPRESSING DRUGS
US5506210A (en) * 1988-08-19 1996-04-09 The Australian National University Phosphosugar-based anti-inflammatory and/or immunosuppressive drugs
DE10164711A1 (en) * 2001-03-13 2002-10-17 Schebo Biotech Ag Use of sugar phosphates, sugar phosphate analogs, amino acids and / or amino acid analogs for modulating the glycolysis-enzyme complex, the malate aspartate shuttle and / or the transaminases
DE202011001556U1 (en) 2011-01-15 2012-04-18 Bernhard Lucas Faltladenanordnung with several self-contained Faltladenelementen with alternately kinking and not buckling element edges

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1158456A (en) * 1967-06-13 1969-07-16 Prodotti Antibiotici Spa Preparations Containing Sugars
US4546095A (en) * 1980-07-21 1985-10-08 Markov Angel K Use of fructose-1,6-diphosphate for treating myocardial infarction
IT1170618B (en) * 1981-01-13 1987-06-03 Foscama Biomed Chim Farma PHARMACOLOGICAL PREPARATION OF SIO-1,6-DIPHOSPHATE FRUIT WITH THERAPEUTIC ACTION IN BURNED PATIENTS

Also Published As

Publication number Publication date
IT1204764B (en) 1989-03-10
FR2600892A1 (en) 1988-01-08
JPS62228020A (en) 1987-10-06
GB8701058D0 (en) 1987-02-18
FR2600892B1 (en) 1991-06-21
GB2185398A (en) 1987-07-22
GB2185398B (en) 1990-06-13
DE3701162A1 (en) 1987-07-23

Similar Documents

Publication Publication Date Title
DK253988A (en) PHARMACEUTICAL PREPARATION CONTAINING EPERISON OR TOLPERISON, OR ANY SALT THEREOF, FOR ADMINISTRATION BY THE SKIN
FI881579A0 (en) ANTICANCER THERAPY OCH CYTOTOXIC LAEKEMEDEL FOER UTFOERANDET DAERAV.
IT8619625A0 (en) PHARMACEUTICAL COMPOSITIONS FOR INHALATION.
IT8622683A0 (en) THERAPEUTIC DEVICE FOR THE ADMINISTRATION OF MEDICINES.
MX9203543A (en) MEDICINE.
FI871750L (en) NASAL ADMINISTRATION AV LAEKEMEDEL.
MY101207A (en) Treatment of diseases caused by retroviruses
FI873010A7 (en) Nitrofuran derivatives, their preparation and their therapeutic application.
EP0305117A3 (en) 2',3'-dideoxy-3'-fluorothymidine and related compounds for the treatment of adenovirus infections
DE69322251D1 (en) MEDICAL COMPOSITION
DE3780257D1 (en) PASSIVE DRUG ADMINISTRATION SYSTEM.
FR2621818B1 (en) MEDICINE COMPRISING THE COMBINATION OF POLYMIXIN B, NETILMICIN AND AMPHOTERICIN B BY VAPORIZATION
NO892764D0 (en) MEDICINAL ADMINISTRATION FOR DRUGS.
NO883047L (en) SUBSTITUTED BENZIMIDAZOLES, PROCEDURES FOR THEIR PREPARATION, PHARMACEUTICAL PREPARATIONS CONTAINING THEIR USE.
FR2597478B1 (en) BENZIMIDAZOLES AND IMIDAZOPYRIDINES SULFONAMIDES, THEIR PREPARATION AND THEIR APPLICATION AS MEDICAMENTS.
IT8619109A0 (en) THERAPEUTIC USE OF FRUCTOSE-1,6-DIPHOSPHATE FOR PROTECTION AGAINST TOXICITY INDUCED BY THE ADMINISTRATION OF ANTHRACYCLINICAL ANTI-CANCER DRUGS.
IT9019793A0 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING IPRIFLAVONE, PROCEDURE FOR THEIR PREPARATION AND RELATED THERAPEUTIC USE
IT8722501A0 (en) PHARMACEUTICAL FORMULATIONS FOR TRANSDERMAL ADMINISTRATION.
NO168040C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 3'-DEMETOXYPIPODOPHYLLOTOXIN GLUCOSIDE DERIVATIVES.
IT8722647A0 (en) PHARMACEUTICAL COMPOSITION FOR NASAL ADMINISTRATION.
IT8821570A0 (en) USE OF ADENOSINE DERIVATIVES FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS HAVING IMMUNOSTIMULANT ACTIVITY.
IT1213568B (en) IMIDAZOLIC DERIVATIVES THERAPEUTIC ADAPTITY, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
FI874643A0 (en) THERAPEUTIC MEDICINAL PRODUCT.
DK80087D0 (en) PHARMACEUTICAL PREPARATION FOR PARENTERAL ADMINISTRATION
FR2390421A1 (en) 1-ACYL-2-HYDROXY-1,3-DIAMINOPROPANES AS NEW MEDICINES